Schizophrenia Sufferer’s Hostile Behavior Ignored by Mental Health System

Schizophrenia Sufferer’s Hostile Behavior Ignored by Mental Health System

Antony Waterlow, a schizophrenia sufferer who stabbed his father Nick Waterlow and his sister Chloe Heuston to death, was never found too sick to be detained by the mental health system. Nick Waterlow, 68, and Chloe Heuston, 36, were killed by Antony at their home in Sydney in 2009.

The NSW Supreme Court couldn't charge him of the murders since he was found mentally ill with a chronic condition called schizophrenia. The mental health system always ignored the man saying he never posed too big a risk to be hospitalized for the illness.

Had the medical experts taken the case serious, the murders could have been avoided. Peter McGeorge, a Psychiatrist at Sydney's St Vincent's Hospital who treated Anthony from November 2006 to February 2007, asserted that the decision to deny Antony of scheduling at the facility was taken in consultation with other psychiatrists.

The discussions over the amendment of the Mental Health Act rose after Antony murdered his father and sister. "He told me that he hid in the corner - he had to hide because people were watching him and making comments about him", said Gaye Bell, one of Antony's friends, to the inquiring officers in the case.

Schizophrenia is a mental disorder that makes the person unable to make differentiate between real and fake or think clearly. The sufferers exhibit abnormal emotional responses.

General: 
Region: 

Popular Stories

Erosion of beaches will get worse: researchers warn

Portraying a gloomy picture of the future, the 2015... Read More

Rare rat-linked disease leaves 1 dead, 2 sickened in Bronx

A rare bacterial disease carried by rats has killed... Read More

Try drug-free remedies before resorting to medication for low back pain: ACP

People suffering low back pain should try drug-free... Read More

Pregnant inmate forced to deliver baby on jail cell floor

A Detroit-area sheriff has defended his staff over... Read More

Marathon Pharma to sell decades-old drug to treat DMD for $89,000

Marathon Pharmaceuticals will reportedly market... Read More